Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin

Accession ARO:3007186
Synonym(s)Rv1258c
CARD Short NameMtub_tap_MULT
DefinitionMutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.
AMR Gene Familymultidrug resistant Rv1258c
Drug Classpyrazine antibiotic, isoniazid-like antibiotic, polyamine antibiotic, aminoglycoside antibiotic
Resistance Mechanismantibiotic target alteration
Resistomes with Sequence VariantsMycobacterium tuberculosisg+wgs
Classification12 ontology terms | Show
Parent Term(s)4 ontology terms | Show
+ confers_resistance_to_antibiotic streptomycin [Antibiotic]
+ confers_resistance_to_antibiotic isoniazid [Antibiotic]
+ confers_resistance_to_antibiotic pyrazinamide [Antibiotic]
+ multidrug resistant Rv1258c [AMR Gene Family]
Publications

Liu J, et al. 2019. Front Microbiol 10:216 Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis. (PMID 30837962)

Resistomes

Prevalence of Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 414 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).

Prevalence: protein variant model (view sequences)

SpeciesNCBI ChromosomeNCBI PlasmidNCBI WGSNCBI GIGRDI-AMR2
Mycobacterium tuberculosis0.82%0%0.21%0%0%
Show Perfect Only


Detection Models

Model Type: protein variant model

Model Definition: Protein Variant Models (PVM) perform a similar search as Protein Homolog Models (PHM), i.e. detect protein sequences based on their similarity to a curated reference sequence, but secondarily screen query sequences for curated sets of mutations to differentiate them from antibiotic susceptible wild-type alleles. PVMs are designed to detect AMR acquired via mutation of house-keeping genes or antibiotic targets, e.g. a mutated gyrase resistant to aminocoumarin antibiotics. PVMs include a protein reference sequence (often from antibiotic susceptible wild-type alleles), a curated bit-score cut-off, and mapped resistance variants. Mapped resistance variants may include any or all of single point mutations, insertions, or deletions curated from the scientific literature. A Strict RGI match has a BLASTP bit-score above the curated BLASTP cutoff value and contains at least one curated mutation from amongst the mapped resistance variants, while a Loose RGI match has a bit-score less than the curated BLASTP bit-score cut-off but still contains at least one curated mutation from amongst the mapped resistance variants.

Bit-score Cut-off (blastP): 700

PubMed: mutation data hand curated from the scientific literature, evaluated as conferring resistance (R). CRyPTIC: mutation data acquired from the CRyPTIC catalog, evaluated as resistant (R), susceptible (S), or undetermined (U). ReSeqTB: mutation data acquired from the ReSeqTB catalog, evaluated as conferring resistance (Minimal, Moderate, High), not conferring resistance (None), or Indeterminate. WHO: mutation data acquired from the WHO 2023 catalog, evaluated as resistant (R), susceptible (S), or undetermined (U).

MutationMutation typePubMedReSeqTBCRyPTICWHO
V219Asingle resistance variantPMID:30837962no datano datano data
S292Lsingle resistance variantPMID:30837962no datano datano data

>gb|NP_215774.1|-|Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin [Mycobacterium tuberculosis H37Rv]
MRNSNRGPAFLILFATLMAAAGDGVSIVAFPWLVLQREGSAGQASIVASATMLPLLFATL
VAGTAVDYFGRRRVSMVADALSGAAVAGVPLVAWGYGGDAVNVLVLAVLAALAAAFGPAG
MTARDSMLPEAAARAGWSLDRINGAYEAILNLAFIVGPAIGGLMIATVGGITTMWITATA
FGLSILAIAALQLEGAGKPHHTSRPQGLVSGIAEGLRFVWNLRVLRTLGMIDLTVTALYL
PMESVLFPKYFTDHQQPVQLGWALMAIAGGGLVGALGYAVLAIRVPRRVTMSTAVLTLGL
ASMVIAFLPPLPVIMVLCAVVGLVYGPIQPIYNYVIQTRAAQHLRGRVVGVMTSLAYAAG
PLGLLLAGPLTDAAGLHATFLALALPIVCTGLVAIRLPALRELDLAPQADIDRPVGSAQ



>gb|NC_000962.3|-|1406081-1407340|Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin [Mycobacterium tuberculosis H37Rv]
ATGAGAAACAGCAACCGCGGCCCGGCATTCCTGATCCTGTTCGCAACGCTGATGGCGGCCGCGGGTGATGGCGTCTCGATAGTCGCGTTT
CCGTGGCTGGTGTTGCAGCGCGAGGGCAGCGCTGGGCAGGCCTCGATCGTGGCCAGTGCGACCATGCTGCCGCTGTTGTTCGCCACGCTG
GTCGCCGGCACCGCGGTCGACTACTTCGGGCGTCGCCGGGTGTCGATGGTGGCCGATGCGCTGTCGGGTGCGGCGGTGGCCGGCGTCCCC
CTGGTGGCGTGGGGGTACGGCGGCGACGCGGTCAACGTGCTGGTGCTGGCCGTATTGGCCGCCCTGGCGGCCGCCTTCGGCCCGGCAGGC
ATGACGGCTCGTGACTCGATGCTGCCCGAGGCCGCCGCTCGGGCAGGCTGGTCGTTGGACCGCATCAACGGCGCCTACGAGGCGATCCTC
AACCTGGCCTTTATTGTCGGCCCGGCCATCGGTGGCTTGATGATCGCGACGGTTGGCGGCATCACCACAATGTGGATTACCGCGACGGCA
TTCGGGTTGTCCATCCTCGCGATTGCCGCCCTGCAACTCGAGGGTGCCGGCAAGCCGCACCACACCTCGCGGCCCCAAGGGTTGGTATCC
GGGATCGCCGAGGGGCTGCGCTTCGTCTGGAACCTGCGGGTATTGCGCACCCTCGGGATGATTGACCTGACCGTCACCGCGCTGTATCTG
CCGATGGAGAGCGTGCTGTTCCCGAAATACTTCACCGACCACCAGCAACCGGTGCAGCTGGGTTGGGCGTTGATGGCGATCGCCGGCGGC
GGCCTGGTGGGAGCGCTGGGGTATGCCGTGTTGGCTATCCGCGTTCCCCGTCGCGTGACCATGTCGACCGCGGTTCTTACCCTGGGTTTG
GCATCGATGGTCATCGCGTTCCTGCCGCCACTGCCGGTCATCATGGTGTTGTGCGCGGTGGTCGGCCTGGTGTACGGACCCATCCAGCCG
ATCTATAACTACGTGATACAGACGCGGGCAGCACAGCATCTGCGCGGCCGGGTAGTCGGGGTGATGACGTCGCTGGCCTACGCCGCCGGC
CCGTTGGGTCTGTTGCTGGCCGGTCCACTGACCGACGCCGCTGGACTGCATGCCACGTTTCTCGCGTTGGCACTGCCCATCGTGTGCACC
GGGCTGGTCGCGATCCGGCTGCCCGCGCTGCGCGAACTGGATCTGGCGCCCCAAGCGGACATCGATCGGCCCGTAGGATCGGCTCAGTGA

Curator Acknowledgements
Curator Description Most Recent Edit